(1R)-7-FLUORO-1,2,3,4-TETRAHYDRONAPHTHYLAMINE, 95.0%, 250mg

7-Methyl-2-((7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino)-9-(tetrahydro-2H-pyran-4-yl)-7H-purin-8(9H)-one, 98.0%, 50mg

(R)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one, 95.0%, 10g

4-Hydroxy-6-methyl-2-(trifluoromethyl)quinoline, 97.0%, 1g

Z-Trp-OMe, 95+%, 100g

1-[(1,4-diazepan-1-yl)methyl]cyclobutan-1-ol, 95.0%, 500mg

(7R,8aS)-2-benzyl-7-hydroxy-octahydropyrrolo[1,2-a]piperazine-1,4-dione, 95.0%, 5g

2-(4-Chloro-phenyl)-benzooxazol-5-ylamine, 95.0%, 1g

1-Ethyl-4-((4-(trans-4-propylcyclohexyl)phenyl)ethynyl)benzene, 97%, 100g

5-Fluorobenzo[d][1,3]dioxole-4-carbaldehyde, 95%, 1g

3-Bromo-5-(4-methylbenzylsulfonyl)-1,2,4-thiadiazole, 250mg

Eslabón de destilación, 350 mm, 29/32, 1 Pieza

4-(2-(Piperidin-1-yl)ethoxy)benzoic acid hydrochloride, 95.0%, 10g